ACTIVE

APCOR R&M

Financial year 2025 · Closed on 31/12/2025

Net result-14,8 k €+51,3 %over 1 year

Gross margin-11,4 k €+10,3 %over 1 year

Equity-359,2 k €-4,3 %over 1 year

Identity

Source · BCE/KBO

APCOR R&M is a Private limited company incorporated in 2015. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Gent.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0600.952.909
Incorporation: 10/03/2015
Legal form: Private limited company
Registered office: Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map
Contributed capital: 400 000,00 €
Latest accounts: 31/12/2025

Activities (NACE)

21100Manufacture of basic pharmaceutical products· main 21100Manufacture of basic pharmaceutical products 46751Wholesale of chemical products 46851Wholesale trade, except of motor vehicles and motorcycles 72109Research and experimental development on natural sciences and engineering 72190Other research and experimental development on natural sciences and engineering+2

Financials

Source · NBB, 11 filings

Trend over 10 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	-11,4 k €	+10.3%	-12,7 k €	-2.6%	-12,4 k €	+9.1%	-13,6 k €	+34.2%	-20,7 k €
EBITDA	-12 k €	+12.4%	-13,6 k €	-8.9%	-12,5 k €	+11.2%	-14,1 k €	+33.5%	-21,2 k €
Operating result	-14,7 k €	+51.3%	-30,3 k €	-3.8%	-29,1 k €	+41.2%	-49,6 k €	+13.9%	-57,6 k €
Net result	-14,8 k €	+51.3%	-30,3 k €	-3.8%	-29,2 k €	+41.2%	-49,6 k €	+13.9%	-57,6 k €
Balance sheet
Equity	-359,2 k €	-4.3%	-344,4 k €	-9.6%	-314,1 k €	-10.2%	-284,9 k €	-21.1%	-235,3 k €
Total assets	5,7 k €	-24.6%	7,5 k €	-67.6%	23,2 k €	-40.4%	39 k €	-47.8%	74,6 k €
Cash	405,5 €	-34.7%	620,9 €	+348%	138,5 €	-75.0%	553,8 €	+66.2%	333,2 €
Debts	364,9 k €	+3.7%	351,9 k €	+4.3%	337,3 k €	+4.1%	323,9 k €	+4.5%	309,9 k €

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Estate&Co0837.628.553Represented by Rina Werbrouck	DirectorManager2016 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Rina Werbrouck	Director2022 accountsManager2018 accounts
Wildemeersch Dirk	Manager2017 accounts

Other companies at this address

Technologiepark-Zwijnaarde 82 9052 Gent

Company	CBE no.
Amalus Therapeutics● Bankrupt	0803.929.268
Ardoyen● Active	0875.102.821
AVROXA● Active	0687.774.936
Benebiose● Active	0784.521.548
BioNeering● Active	0807.194.309
CONTREL EUROPE● Active	0426.204.637
CRODEON TECHNOLOGIES● Active	0642.754.761
Cryptobiotix● Active	0762.565.104
Gulliver Biomed● Active	0692.527.837
ImplicitMeasures.com● Bankrupt	0657.989.701
Inbiose● Active	0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active	0440.054.752
INNOVATIVE PHARMACEUTICS● Active	0883.574.582
Inspect● Active	0645.950.417
INVIBES ADVERTISING● Active	0836.533.938
KYTOS● Active	0768.755.286
Lares Solutions● Active	1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active	0755.350.975
Microbial Resource Management Health● Active	0742.910.132
Microbial Resource Management Technologies● Active	0667.765.816

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	29/08/2025	29/08/2024	31/08/2023	27/08/2022	30/07/2021
General meeting	04/05/2026	05/05/2025	06/05/2024	02/05/2023	02/05/2022	03/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 11 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	04/05/2026	31/08/2026	Dutch	PDF
Abridged model	31/12/2024	05/05/2025	29/08/2025	Dutch	PDF
Abridged model	31/12/2023	06/05/2024	29/08/2024	Dutch	PDF
Micro model	31/12/2022	02/05/2023	31/08/2023	Dutch	PDF
Micro model	31/12/2021	02/05/2022	27/08/2022	Dutch	PDF
Micro model	31/12/2020	03/05/2021	30/07/2021	Dutch	PDF
Micro model	31/12/2019	14/08/2020	14/09/2020	Dutch	PDF
Micro model	31/12/2018	06/05/2019	30/08/2019	Dutch	PDF
Micro modelCorrection	31/12/2017	28/06/2018	25/07/2018	Dutch	PDF
Micro model	31/12/2017	07/05/2018	24/07/2018	Dutch	PDF
Abridged model	31/12/2016	02/05/2017	30/06/2017	Dutch	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Estate&Co0837.628.553Represented by Rina Werbrouck	DirectorManager2016 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Rina Werbrouck	Director2022 accountsManager2018 accounts
Wildemeersch Dirk	Manager2017 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates01/02/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/03/2019
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/08/2017
ONTSLAGEN - BENOEMINGEN
PDF
Other25/03/2015
oprichting
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings10 filings

Mandates

Estate&Co

Rina Werbrouck

Wildemeersch Dirk

201520162017201820192020202120222023202420252026

APCOR R&M

Technologiepark-Zwijnaarde 82, 9052 Zwijnaarde

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Technologiepark-Zwijnaarde 82, 9052 ZwijnaardeCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00496474

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
APCOR R&MCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00496474

Events

2025
Annual accounts 2025-14,8 k €↑
2024
Annual accounts 2024-30,3 k €↓
2023
Annual accounts 2023-29,2 k €↑
2022
Annual accounts 2022-49,6 k €↑
2021
Annual accounts 2021-57,6 k €↓
2020
Annual accounts 2020-47,4 k €↑
2019
Annual accounts 2019-121,8 k €↑
2018
Annual accounts 2018-141 k €↑
2017
Annual accounts 2017-165,5 k €↓
2016
Annual accounts 2016-101,9 k €
10/03/2015
IncorporationPrivate limited company

APCOR R&M

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events